Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy.
about
Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative reviewAbuse and misuse of antidepressantsThe interface between substance abuse and chronic pain management in primary care: a curriculum for medical residents.Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.Improving opioid prescription practices and reducing patient risk in the primary care setting.Opioid contracts and random drug testing for people with chronic pain - think twice.Practical guide to the management of acute and chronic pain in the presence of drug tolerance for the healthcare practitioner.Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant resultsDenial of urinalysis-confirmed opioid use in prescription opioid dependenceSystematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorderThe subjective, reinforcing, and analgesic effects of oxycodone in patients with chronic, non-malignant pain who are maintained on sublingual buprenorphine/naloxone.Computerized progress notes for chronic pain patients receiving opioids; the Prescription Opioid Documentation System (PODS).Opioids and the treatment of chronic pain: controversies, current status, and future directions.Racial differences in primary care opioid risk reduction strategiesLow use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain.Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder.Promethazine use among chronic pain patientsThe Relationship Between Drug Use, Drug-related Arrests, and Chronic Pain Among Adults on Probation.Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individualsMisuse of and dependence on opioids: study of chronic pain patients.Long-term opioid contract use for chronic pain management in primary care practice. A five year experience.The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation StrategyCurrent knowledge on cannabinoids in oral fluid.Opioid tolerance and dependence -- do they matter?Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuseThey don't know what they don't know: internal medicine residents' knowledge and confidence in urine drug test interpretation for patients with chronic painRisk for prescription opioid misuse among patients with a history of substance use disorderPalliative care of the terminally ill drug addict."Safe and effective when used as directed": the case of chronic use of opioid analgesics.Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.Prescription opioid abuse: challenges and opportunities for payers.Managing pain in high-risk patients within a patient-centered medical home.Update on prescription extended-release opioids and appropriate patient selection.Management of opioid analgesic overdosePsychological approaches in the treatment of chronic pain patients--when pills, scalpels, and needles are not enough.What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.Patients as collaborators: using focus groups and feedback sessions to develop an interactive, web-based self-management intervention for chronic pain.Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
P2860
Q26744035-09ED1C8E-C913-4FAA-8AA5-54CF7CCF1435Q27691354-D12C420E-576B-4D01-A238-275867E57CF8Q30435731-963AFC67-8DD6-4104-BEC4-0CE2504F8E9CQ33238894-7E0EEF81-52D0-401A-8C30-AA328A14BDE0Q33705809-856C9F6C-5F23-4AF8-866F-A4121DDADF1FQ33774111-A0807030-56CD-4DEB-9837-C6F45492C300Q34096112-056BFB84-3535-4889-822F-010B2B92CC29Q34228635-F158E4C2-DF55-49DD-9557-FAFC9C82B5C2Q34566925-0FBE6B11-C84A-4FEF-BA3F-86BB0F47AE5EQ34602901-6A0A0E39-CA02-4DAD-B894-076B7C4B15DDQ34644900-9E0A2E0F-6AAD-4C44-9DE2-30A8F40027EBQ34661770-14C7FB01-F04C-4690-8119-148DC611281BQ34682953-6BB5DD20-3A11-405C-9333-F91EFF2FB0C5Q34846394-BF74375D-5764-49FE-9155-04F96B0AF411Q34958037-0DD656E3-442B-4D44-9BC6-2010EC661EE2Q35168938-9D32DA09-17AA-4C05-A436-6B991DF8FBAFQ35168963-89E6BD81-7C5C-4F38-93B3-4400EFBC11F5Q35318730-81D60372-363A-4111-94D8-B07105252FFCQ35553915-C709219A-EA0F-49E3-AB60-DFAE6B49DA87Q35592677-3B9F89A1-9E5C-4C01-B252-17DD013E52B4Q35613256-734CD67C-5D54-4CDD-81E6-01124C81D8C6Q35691483-8FD4BEE6-57BF-49BC-8398-604A051F0379Q35940208-28D82A93-3DB9-4438-AF7C-9F53F8B5EA3CQ35940339-59B40BF9-7ACD-4205-8E44-8C5E833626CFQ36057770-E3302F01-28A7-407F-851B-A9AB32F310A7Q36083505-E9647A86-AC43-44D3-9505-197DF0E75AAAQ36331475-1D18018C-D992-40E0-A29D-EC51105B0630Q36357013-CDE532F5-551D-4407-ADB5-537F7BA71FDEQ36508088-EFD95FFC-4CB1-46BB-B77E-C6E88BA01583Q36549016-437EB0C8-04D0-4249-9A40-1A699E62A6F7Q36729404-B9729916-3A94-40B5-B2DC-C42413A58EEDQ36742039-2B3DA2E7-BAC0-42E8-BE44-2EBAC30948F1Q36922546-FD92F3F3-6974-4FBE-9B44-4B5183FDF7B0Q37030946-79B634BA-AF80-4E8C-94EE-2901961F78DFQ37053718-55477162-F72C-4A82-AD24-81D8E228A84DQ37084008-A9AD5D06-F6C4-4127-AF90-BBCFB57BE993Q37163277-66B062F3-DA16-4CED-B5B6-408A0DAA4CD0Q37167680-0BA4F5C8-2328-4BB7-A392-1B2493B6D94BQ37325568-D8B5F3B4-ECD4-4912-BE5D-666FE0D9F94FQ37549796-222C38D0-8C0A-4CE0-B622-05F308DE48DF
P2860
Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Behavioral monitoring and urin ...... ving long-term opioid therapy.
@en
Behavioral monitoring and urin ...... ving long-term opioid therapy.
@nl
type
label
Behavioral monitoring and urin ...... ving long-term opioid therapy.
@en
Behavioral monitoring and urin ...... ving long-term opioid therapy.
@nl
prefLabel
Behavioral monitoring and urin ...... ving long-term opioid therapy.
@en
Behavioral monitoring and urin ...... ving long-term opioid therapy.
@nl
P2093
P1476
Behavioral monitoring and urin ...... ving long-term opioid therapy.
@en
P2093
Gilbert J Fanciullo
Janet Vielguth
Joyce Bradley
Michael Beach
Nathaniel P Katz
Robert J Rose
Summer Sherburne
P304
1097-102, table of contents
P356
10.1213/01.ANE.0000080159.83342.B5
P407
P577
2003-10-01T00:00:00Z